BiotechTube
EGeen

EGeen

Cambridge, United States· Est.
egeeninc.com
Is this your company? Claim your profile to update info and connect with investors.
Claim profile

Private Company

Funding information not available

Overview

EGeen International is a private, revenue-generating CRO founded in 2019 and headquartered in Cambridge, USA, with a significant operational presence across Europe and other global regions. The company offers end-to-end clinical development services, with a noted specialty in generic drug development and rapid patient recruitment, primarily serving clients in cardiology, oncology, neurology, and ophthalmology. Led by CEO Rauno Oja and founder Kalev Kask, EGeen positions itself as a rapid-response partner for advancing drug development programs through efficient trial execution.

CardiologyOncologyGastro-intestinalNeurologyCNSOpthalmologyUrologyWomen's HealthDermatology

Technology Platform

Integrated global CRO service platform specializing in rapid patient recruitment, clinical trial management, and a dedicated Generic Drug Development (GDD) program leveraging European trial efficiencies.

Opportunities

The growing trend of pharmaceutical outsourcing and the consistent demand for efficient generic drug development present significant opportunities.
EGeen's established European operational network is a key asset for sponsors seeking cost-effective and rapid clinical trial execution in that region.

Risk Factors

Faces intense competition from larger, resource-rich CROs, and its success is partially dependent on client trial outcomes beyond its control.
Operational risks include patient recruitment challenges, maintaining quality across a global contractor network, and complex international regulatory compliance.

Competitive Landscape

EGeen competes in the fragmented global CRO market against large, full-service players (e.g., IQVIA, ICON) and numerous niche or regional CROs. Its differentiation is based on rapid patient recruitment, cost-effectiveness, and a specialized focus on generic drug development through its European GDD Program.

More companies in Digital Health & Biotech SaaS →More companies in United States →